Clinical Trial Update: Study of SA+X in the Treatment of Newly Diagnosed AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SA+X for newly diagnosed acute myeloid leukemia is currently recruiting at Ruijin Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• SA+X

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING